Literature DB >> 23205288

Perfusing chemotherapy by percutaneous lung puncture in the treatment of extensive drug resistant pulmonary tuberculosis.

Shu-Hua Yang1, Ping Zhan, Mei Sun, Ya-Ping Zhang, Nan-Lan Ma.   

Abstract

Although progress has been made to reduce global incidence of drug-susceptible tuberculosis, the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) during the past decade threatens to undermine these advances. XDR-TB has been found to be associated with scarce therapeutic options and high mortality rates. We describe the first case of XDR-TB cured by percutaneous lung puncture and with post-hospital 4 years follow-up involving radiologic imaging and septum smear and TB culture. We also review the epidemiology, diagnosis and treatment of tuberculosis all the world.

Entities:  

Keywords:  Multidrug-resistant (MDR); chemotherapy; extensively drug-resistant (XDR); extensively drug-resistant tuberculosis (XDR-TB); percutaneous lung puncture

Year:  2012        PMID: 23205288      PMCID: PMC3506796          DOI: 10.3978/j.issn.2072-1439.2012.06.09

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  6 in total

Review 1.  Clinical practice. Latent tuberculosis infection.

Authors:  Robert M Jasmer; Payam Nahid; Philip C Hopewell
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes.

Authors:  Shenjie Tang; Qing Zhang; Jinming Yu; Yidian Liu; Wei Sha; Hua Sun; Lin Fan; Jin Gu; Xiaohui Hao; Lan Yao; Heping Xiao
Journal:  Scand J Infect Dis       Date:  2011-01-19

Review 3.  Tuberculosis.

Authors:  Stephen D Lawn; Alimuddin I Zumla
Journal:  Lancet       Date:  2011-03-21       Impact factor: 79.321

4.  An immunochromatographic serological assay for the diagnosis of Mycobacterium tuberculosis.

Authors:  J R Reddy; J Kwang; K F Lechtenberg; N C Khan; Reddy B Prasad; M M Chengappa
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2002-01       Impact factor: 2.268

Review 5.  Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.

Authors:  Abigail Wright; Matteo Zignol; Armand Van Deun; Dennis Falzon; Sabine Ruesch Gerdes; Knut Feldman; Sven Hoffner; Francis Drobniewski; Lucia Barrera; Dick van Soolingen; Fadila Boulabhal; C N Paramasivan; Kai Man Kam; Satoshi Mitarai; Paul Nunn; Mario Raviglione
Journal:  Lancet       Date:  2009-04-15       Impact factor: 79.321

6.  Progress in tuberculosis control and the evolving public-health system in China.

Authors:  Longde Wang; Jianjun Liu; Daniel P Chin
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

  6 in total
  2 in total

1.  Perfusing chemotherapy by percutaneous lung puncture "holing" for pulmonary tuberculoma-a ten-year single center experience.

Authors:  Shu-Hua Yang; Ping Zhan; Hui-Huan Mao; Xu-Dong Shi; Ling-Ling Wang
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

2.  The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis.

Authors:  Mohsen Heidary; Saeed Zaker Bostanabad; Seyed Mohammad Amini; Alireza Jafari; Mostafa Ghalami Nobar; Arash Ghodousi; Morteza Kamalzadeh; Davood Darban-Sarokhalil
Journal:  Infect Drug Resist       Date:  2019-11-04       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.